TargetDual specificity mitogen-activated protein kinase kinase 1/2(Homo sapiens (Human))
Ucb Pharma
Curated by ChEMBL
Ucb Pharma
Curated by ChEMBL
Affinity DataIC50: 6nMAssay Description:Inhibition of human MEK using fluorescein-labelled Erk-tide as substrate after 20 mins by IMAP assayMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1/2(Homo sapiens (Human))
Ucb Pharma
Curated by ChEMBL
Ucb Pharma
Curated by ChEMBL
Affinity DataIC50: 7nMAssay Description:Inhibition of human MEK using fluorescein-labelled Erk-tide as substrate after 20 mins by IMAP assayMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1/2(Homo sapiens (Human))
Ucb Pharma
Curated by ChEMBL
Ucb Pharma
Curated by ChEMBL
Affinity DataIC50: 8nMAssay Description:Inhibition of human MEK using fluorescein-labelled Erk-tide as substrate after 20 mins by IMAP assayMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1/2(Homo sapiens (Human))
Ucb Pharma
Curated by ChEMBL
Ucb Pharma
Curated by ChEMBL
Affinity DataIC50: 9nMAssay Description:Inhibition of human MEK using fluorescein-labelled Erk-tide as substrate after 20 mins by IMAP assayMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1/2(Homo sapiens (Human))
Ucb Pharma
Curated by ChEMBL
Ucb Pharma
Curated by ChEMBL
Affinity DataIC50: 9nMAssay Description:Inhibition of human MEK using fluorescein-labelled Erk-tide as substrate after 20 mins by IMAP assayMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1/2(Homo sapiens (Human))
Ucb Pharma
Curated by ChEMBL
Ucb Pharma
Curated by ChEMBL
Affinity DataIC50: 13nMAssay Description:Inhibition of human MEK using fluorescein-labelled Erk-tide as substrate after 20 mins by IMAP assayMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1/2(Homo sapiens (Human))
Ucb Pharma
Curated by ChEMBL
Ucb Pharma
Curated by ChEMBL
Affinity DataIC50: 14nMAssay Description:Inhibition of human MEK using fluorescein-labelled Erk-tide as substrate after 20 mins by IMAP assayMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1/2(Homo sapiens (Human))
Ucb Pharma
Curated by ChEMBL
Ucb Pharma
Curated by ChEMBL
Affinity DataIC50: 14nMAssay Description:Inhibition of human MEK using fluorescein-labelled Erk-tide as substrate after 20 mins by IMAP assayMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1/2(Homo sapiens (Human))
Ucb Pharma
Curated by ChEMBL
Ucb Pharma
Curated by ChEMBL
Affinity DataIC50: 18nMAssay Description:Inhibition of human MEK using fluorescein-labelled Erk-tide as substrate after 20 mins by IMAP assayMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1/2(Homo sapiens (Human))
Ucb Pharma
Curated by ChEMBL
Ucb Pharma
Curated by ChEMBL
Affinity DataIC50: 22nMAssay Description:Inhibition of human MEK using fluorescein-labelled Erk-tide as substrate after 20 mins by IMAP assayMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1/2(Homo sapiens (Human))
Ucb Pharma
Curated by ChEMBL
Ucb Pharma
Curated by ChEMBL
Affinity DataIC50: 28nMAssay Description:Inhibition of human MEK using fluorescein-labelled Erk-tide as substrate after 20 mins by IMAP assayMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1/2(Homo sapiens (Human))
Ucb Pharma
Curated by ChEMBL
Ucb Pharma
Curated by ChEMBL
Affinity DataIC50: 42nMAssay Description:Inhibition of human MEK using fluorescein-labelled Erk-tide as substrate after 20 mins by IMAP assayMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1/2(Homo sapiens (Human))
Ucb Pharma
Curated by ChEMBL
Ucb Pharma
Curated by ChEMBL
Affinity DataIC50: 200nMAssay Description:Inhibition of human MEK using fluorescein-labelled Erk-tide as substrate after 20 mins by IMAP assayMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1/2(Homo sapiens (Human))
Ucb Pharma
Curated by ChEMBL
Ucb Pharma
Curated by ChEMBL
Affinity DataIC50: 226nMAssay Description:Inhibition of human MEK using fluorescein-labelled Erk-tide as substrate after 20 mins by IMAP assayMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1/2(Homo sapiens (Human))
Ucb Pharma
Curated by ChEMBL
Ucb Pharma
Curated by ChEMBL
Affinity DataIC50: 305nMAssay Description:Inhibition of human MEK using fluorescein-labelled Erk-tide as substrate after 20 mins by IMAP assayMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1/2(Homo sapiens (Human))
Ucb Pharma
Curated by ChEMBL
Ucb Pharma
Curated by ChEMBL
Affinity DataIC50: 309nMAssay Description:Inhibition of human MEK using fluorescein-labelled Erk-tide as substrate after 20 mins by IMAP assayMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1/2(Homo sapiens (Human))
Ucb Pharma
Curated by ChEMBL
Ucb Pharma
Curated by ChEMBL
Affinity DataIC50: 456nMAssay Description:Inhibition of human MEK using fluorescein-labelled Erk-tide as substrate after 20 mins by IMAP assayMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1/2(Homo sapiens (Human))
Ucb Pharma
Curated by ChEMBL
Ucb Pharma
Curated by ChEMBL
Affinity DataIC50: 946nMAssay Description:Inhibition of human MEK using fluorescein-labelled Erk-tide as substrate after 20 mins by IMAP assayMore data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1/2(Homo sapiens (Human))
Ucb Pharma
Curated by ChEMBL
Ucb Pharma
Curated by ChEMBL
Affinity DataIC50: 2.62E+3nMAssay Description:Inhibition of human MEK using fluorescein-labelled Erk-tide as substrate after 20 mins by IMAP assayMore data for this Ligand-Target Pair